Skip to main content

Table 1 Demographic, clinical and laboratory data of the patients

From: Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes

Variable

MS according to NCEP-ATP III criteria

MS according to IDF criteria

With MS (n = 364)

Without MS (n = 136)

p value

With MS (n = 419)

Without MS (n = 81)

p value

Age (years)*

65.9 ± 10.0

62.0 ± 12.9

0.002

65.6 ± 10.2

61.6 ± 13.6

0.010

Diabetes duration (years)

12.7 ± 8.4

11.5 ± 8.5

0.166

12.5 ± 8.3

11.7 ± 8.9

0.389

BMI (kg/m 2 )

30.0 ± 5.2

26.7 ± 4.3

<0.001

29.9 ± 5.0

25.9 ± 4.8

<0.001

Waist (cm) males

108 ± 11

98 ± 9

<0.001

107 ± 10

95 ± 11

<0.001

Waist (cm) females

105 ± 9

89 ± 17

<0.001

104 ± 10

89 ± 20

<0.001

Serum HDL (mg/d) males

42 ± 10

51 ± 11

<0.001

44 ± 11

51 ± 12

<0.001

Serum HDL (mg/dl) females

49 ± 10

61 ± 10

<0.001

50 ± 11

61 ± 10

<0.001

Serum triglycerides (mg/dl)

172 ± 91

106 ± 50

<0.001

164 ± 90

111 ± 57

<0.001

SBP (mmHg)

134 ± 19

126 ± 14

<0.001

134 ± 19

123 ± 11

<0.001

DBP (mmHg)

79 ± 11

75 ± 8

<0.001

79 ± 11

74 ± 6

<0.001

Glycosylated hemoglobin (%)

7.1 ± 1.3

7.0 ± 1.3

0.137

7.1 ± 1.3

7.0 ± 1.3

0.416